LG Electronics is working with virtualisation firm VMware to develop software that secures consumer handsets when used in the enterprise.
The companies explained that the tools will help enterprises of all sizes to improve security and data protection by letting employee-owned devices exist in a virtualised environment.
The first fruit of the partnership will allow employee-owned LG smartphones to run in secure isolation.
Workers will be able to use one device for work and leisure while giving organisations the confidence that sensitive corporate data is safe, the firms said.
The software is expected to be released in the new year, and is an important element of LG's plans to increase its enterprise footprint.
"Our partnership with VMware is part of LG's global strategy to develop smart mobile devices for businesses," said Ki S. Kim, vice president of global enterprise solutions at LG Electronics Mobile Communications.
"Enterprise IT organisations are looking for a way to embrace the growing trend of employee-owned mobile devices at work, while still maintaining control over corporate data."
Ki added that the partnership will serve as a platform for this expansion, and that LG intends to deliver "compelling solutions that address the challenges raised by the convergence of IT and mobile communications".
The service will be extended to mobile devices from other manufacturers in the future, LG said.
IT managers are increasingly concerned about the large numbers of corporate users bringing in personal devices for use in the office, a trend set to continue as smartphones become more powerful and the line between work and leisure blurs further.
Ssupermassive black hole is so big it corresponds to four per cent of the galaxy's total mass
Imminent attack will target a single bank with cloned cards used to fraudulently withdraw millions over one weekend
Using photocatalysts to convert carbon dioxide into usable energy such as methane or ethane
Trained on curated data from Moorfields Eye Hospital, the neural network also shows clinicians how it reached its judgement